The Team

BioCurate’s team brings decades of global experience, scientific and commercial expertise and proven success spanning therapeutic discovery, preclinical, clinical, regulatory and commercial areas. This expertise, together with a passion and commitment to create impact through translating discoveries into drugs, enables the team to recognise and realise real-world impact.

More than 170 years of combined biotech/pharma industry experience

Directly involved in over 13 Investigational New Drug applications (INDs)

Responsible for 30 therapeutics currently in the clinic

Directly involved in deals worth a cumulative total of more than $2.4 billion

Dr Kathy Nielsen
Kathy brings over 25 years of experience in senior leadership and advisory roles primarily in the life science sector, with deep experience in technology transfer, venture capital, creating and advancing spin out companies, and operating in the nexus between research and the pharmaceutical industry.

Read full profile
Dr Christopher Chan
Executive Director, Research and Development
Dr Christopher Chan has significant experience in leading and managing pre-clinical research and translational development of scientific programs, asset and pipeline growth, portfolio management, and program commercialization strategy.

Read full profile
Dr Catherine Drinkwater
Director of Project Management
Dr Cathy Drinkwater has extensive experience in both academic research and industry drug development.

Read full profile
Dr Eric Hayes
Director of Partnerships
Dr Eric Hayes has academic, commercial drug development and pharmaceutical R&D support services experience, spanning over 25 years, in Europe, North America, Asia and Australia.

Read full profile
Dr Andy Allen
Director of Therapeutic Pipeline Programs
Dr Andy Allen has academic, small biotech, and large pharmaceutical company experience spanning over 20 years, in both the UK and Australia.

Read full profile
Dr Jaclyn Sceneay
Director of Biology
Dr Jaclyn Sceneay is an immuno-oncologist with experience in small molecule and PROTAC drug discovery, and microbiome therapeutics.

Read full profile
Dr Frederico Calhabeu
Director of Cell and Gene Therapies
Dr Frederico Calhabeu has over 20 years of experience in the fields of Stem Cell biology, Regenerative Medicine and Oncology, through positions in academia and industry.

Read full profile
Dr Tifelle Reisinger
Associate Director, Medicinal Chemistry Discovery and Stakeholder Management
Dr Tifelle Reisinger is a medicinal chemist with drug discovery experience in the pharmaceutical industry and contract research organisations (CRO) in France, UK and Australia.

Read full profile
Dr Belinda Huff
Associate Director of Small Molecule Therapeutics
Dr Belinda Huff is a medicinal chemist with 8 years drug discovery experience in the pharmaceutical industry.

Read full profile
Dr Heique Bogdawa
Senior Scientist, Protein Sciences
Dr Heique Bogdawa is a biochemist with over 15 years protein engineering experience in the development of high-quality biological reagents and target validation assays for drug discovery.

Read full profile
Dr Julia Beveridge
Scientist, Small Molecule Therapeutics
Dr Julia Beveridge is a medicinal chemist with experience in small molecule and PROTAC drug development.

Read full profile
Francis Kirby
Partnerships and Strategy Manager
Francis Kirby has project management experience in the academic and corporate sector together with a research background in the fields of Neuroscience and Immunology.

Read full profile
Michele Neisemann
Operations Manager
Michele Neisemann has extensive experience in executive administration, human resources, operations, and project management in the R&D sector.

Read full profile

Board of Directors

BioCurate is operationally independent and has an independent Board Chair, the Hon John Brumby, AO. Our Board of Directors has expertise in innovation, biotechnology, commercialisation, investment and corporate governance.

Discover more


Our Shareholders

Melbourne is home to two outstanding universities, Monash University and the University of Melbourne. Joining these two powerhouses to support the collaborative joint venture BioCurate, is the Victorian State Government, the nation’s largest investor in the life sciences.

Discover more



BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.

Discover more